MedTrace Logo

Micro RNA Profile in the Ovarian Follicle Fluid of Transgender Men

NCT03725280 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-10-31

No results posted yet for this study

Summary

The effects of gender transitioning, particularly the effects of testosterone exposure in transgender men, on the oocyte and embryo development are largely unknown. Based on prior studies suggesting that the extracellular RNAs secreted by the ovarian follicle cells reflect the oocyte and embryo biological state, the investigators propose to use these extracellular RNAs to gain insights into the effects of testosterone exposure in transgender men on their oocyte and embryo without impacting the clinical IVF process.

Conditions

Interventions

PROCEDURE

IVF

None interventional study (Collection of ovarian follicular fluid during IVF treatment)

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2021-11-01
Completion
2023-11-01

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03725280 on ClinicalTrials.gov